Sun Pharma Presents Long-Term Leqselvi Data
Sun Pharma presents long-term safety and efficacy data for Leqselvi in adults with severe alopecia areata at the EADV Congress 2026.
Alopecia Areata | 03/10/2026 | By News Bureau
ImageneBio Raises USD 30 Million in Private Placement
ImageneBio has raised USD 30 million in private placement led by Coastlands Capital to advance IMG-007 development in alopecia areata and atopic dermatitis.
Alopecia Areata | 14/04/2026 | By News Bureau | 131
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy